Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

REGISTER for free or LOG IN to view this content

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Coronary

Presentation

TCT 2013

Up Next

Presentation TCT 2013

Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement

Presenter: Nicolas van Mieghem

October 31, 2013

More slides +

Presentation TCT 2015

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Presenter: Robert A. Byrne

October 14, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Roxana Mehran

October 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.